Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

(2023) Andrew H. Karaba et al.   AMERICAN JOURNAL OF TRANSPLANTATION

SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination

(2023) José Luis Piñana et al.   BONE MARROW TRANSPLANTATION

Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination

(2023) José L. Casado et al.   Viruses-Basel

A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies

(2023) Eleonora Sabetta et al.   Frontiers in Immunology

Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series

(2022) Sophie Caillard et al.   ANNALS OF INTERNAL MEDICINE

Response to tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients

(2022) Iddo Z. Ben-Dov et al.   JOURNAL OF NEPHROLOGY

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

(2022) Sue Ann Costa Clemens et al.   LANCET

Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera

(2022) Alexander Muik et al.   SCIENCE

6-mo Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients

(2022) Aura T. Abedon et al.   TRANSPLANTATION

Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients

(2022) Leszek Tylicki et al.   Vaccines

A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant Recipient

(2022) Toralf Roch et al.   Kidney International Reports

Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS‐CoV‐2 vaccine dose in kidney transplant recipients

(2022) Louise Benning et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Fourth dose of the SARS‐CoV ‐2 vaccine in kidney transplant recipients with previously impaired humoral antibody response

(2022) Karsten Midtvedt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine

(2022) Deepali Kumar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore

(2022) M Premikha et al.   CLINICAL INFECTIOUS DISEASES

Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients

(2022) Ayman Al Jurdi et al.   KIDNEY INTERNATIONAL

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

(2022) Ilies Benotmane et al.   KIDNEY INTERNATIONAL

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

(2022) Tommy Nyberg et al.   LANCET

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

(2022) Alasdair P S Munro et al.   LANCET INFECTIOUS DISEASES

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron

(2022) Gili Regev-Yochay et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave

(2022) Jennifer L. Alejo et al.   TRANSPLANTATION

Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept

(2022) Jonathan Mitchell et al.   TRANSPLANTATION

Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil–containing Immunosuppressive Regimens

(2022) Silke E. de Boer et al.   TRANSPLANTATION

Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients

(2022) Ayelet Grupper et al.   TRANSPLANTATION PROCEEDINGS

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

(2022) Jackrapong Bruminhent et al.   Scientific Reports

Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis

(2022) Wing Ying Au et al.   BMJ-British Medical Journal

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients

(2022) Eva Schrezenmeier et al.   JCI Insight

Determinants of Antibody Response to a Third SARS-CoV-2 mRNA Vaccine Dose in Solid Organ Transplant Recipients: Results from the Prospective Cohort Study COVAC-Tx

(2022) Daniel Balsby et al.   Vaccines

Humoral Response to Heterologous SARS-CoV-2 Vaccination in Kidney Transplant Patients Is Heterogeneous and Dose Dependent

(2022) Mariana Seija et al.   Kidney International Reports

Breakthrough COVID‐19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients

(2022) Ilies Benotmane et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study

(2022) S Reshwan K Malahe et al.   CLINICAL INFECTIOUS DISEASES

USE OF REMDESIVIR IN KIDNEY TRANSPLANT RECIPIENTS WITH SARS-COV-2 OMICRON INFECTION

(2022) Judit Cacho et al.   KIDNEY INTERNATIONAL

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

(2022) Gary A Herman et al.   LANCET INFECTIOUS DISEASES

Is the Omicron variant truly less virulent in solid organ transplant recipients?

(2022) Shweta Anjan et al.   Transplant Infectious Disease

COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes

(2022) Germaine Wong et al.   TRANSPLANTATION

Effectiveness and Safety of ANTI SARS-CoV-2 Vaccination in Transplant Patients Treated with Immunosuppressants: A Real-World Pilot Study with a 1-Year Follow-Up

(2022) Alfredo Caglioti et al.   Applied Sciences-Basel

Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis

(2022) Saad Alhumaid et al.   Vaccines

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients

(2022) Irene Cassaniti et al.   Vaccines

Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination—A Non-randomized, Controlled Pilot Study

(2022) Florina Regele et al.   Frontiers in Medicine

Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial

(2022) Andreas Heinzel et al.   Frontiers in Medicine

Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction

(2022) Marta Kantauskaite et al.   CLINICAL TRANSPLANTATION

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

(2022) Spyros Chalkias et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative outcomes after early Sotrovimab administration in vaccinated and unvaccinated kidney transplant recipients with SARS‐CoV‐2 infection during the Delta and Omicron BA.1 surges

(2022) Anantharaman Vathsala et al.   Transplant Infectious Disease

Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review

(2022) Wiebe Külper-Schiek et al.   Frontiers in Immunology

Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients

(2022) Alexandra Tauzin et al.   iScience

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations

(2022) Claudia Maria Trombetta et al.   Communications Biology

Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study

(2022) Borja Quiroga et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients

(2022) Thomas R. McCune et al.   TRANSPLANT IMMUNOLOGY

Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients

(2022) Tina Thomson et al.   EClinicalMedicine

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

(2021) Matthew J Page et al.   BMJ-British Medical Journal

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

(2021) William A. Werbel et al.   ANNALS OF INTERNAL MEDICINE

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

(2021) Ilies Benotmane et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Surveillance for Adverse Events After COVID-19 mRNA Vaccination

(2021) Nicola P. Klein et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

(2021) Ugur Sahin et al.   NATURE

Cellular And Humoral Immune Responses after Three Doses of BNT162b2 mRNA SARS-Cov-2 Vaccine in Kidney Transplant

(2021) Julian Stumpf et al.   TRANSPLANTATION

Immune Response Post-SARS-CoV-2 mRNA Vaccination in Kidney-Transplant Recipients Receiving Belatacept

(2021) Johan Noble et al.   TRANSPLANTATION

B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients

(2021) Eva Schrezenmeier et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

(2021) Alasdair P S Munro et al.   LANCET

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

(2021) Gang Zeng et al.   LANCET INFECTIOUS DISEASES

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients

(2021) Roman Reindl-Schwaighofer et al.   JAMA Internal Medicine

Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients

(2021) Filippo Massa et al.   EBioMedicine

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis

(2018) William R. Mulley et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

(2015) A. Iorio et al.   BMJ-British Medical Journal

Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

(2015) A. Iorio et al.   BMJ-British Medical Journal

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY